ISR News and Press, IsoRay Inc. From 03/17/21

Penny Stocks Trading Higher As $1,400 Stimulus Checks Roll Out Despite the market’s hesitation before the Fed meeting today, penny stocks have remained a broad focus for traders. These highly volatile shares trade for less than $5 and continue attracting swing traders and day...

Penny Stocks To Watch For March 2021 If You Like The Biotech Sector As we approach the third week of March, penny stocks seem to be on a hot streak. This is a combination of the massive decline in covid cases and the $1.9 trillion stimulus package passing. Also, investors’ fear a...

RICHLAND, Wash., March 03, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator, today announced that Chief Executive Officer Lori Woods will present at the Oppenheimer 31 st Annual Healthcare Conference on Wed...

4 Biotech Penny Stocks To Watch Heading Into March 2021 Like any good investor, the key to picking penny stocks to buy is a proper balance between speculation and research. While this applies heavily to biotech penny stocks, there are some additional factors to take into consideration. ...

Are These Penny Stocks On Your Watch List Right Now? What are penny stocks ? According to the U.S. Securities and Exchange Commission, these are shares of companies trading for less than $5. While many traders carry their own definition of penny stocks, this is the standard issue an...

Gainers: Vascular Biogenics (VBLT) +22%, Sunesis Pharmaceuticals (SNSS) +21%, Savara (SVRA) +8%, Pandion Therapeutics (PAND) +5%.Losers: PAVmed (PAVM) -17%, Isoray (ISR) -16%, Vaccinex (VCNX) -16%, Onconova Therapeutics (ONTX) -15%, elect...

IsoRay is a specialist of brachytherapy using proprietary radioactive seeds based on Cesium-131 to cheaply, safely and effectively treat certain cancers. Its main market is that for certain prostate cancer treatments and that has been affected by the pandemic, but there is a large and...

RICHLAND, Wash., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator, today announced that Lisa Lauer has been appointed Vice President, Business Development. CEO Lori Woods says Lauer’s appointment ma...

IsoRay, Inc. (ISR) Q2 2021 Earnings Conference Call February 09, 2021, 04:30 PM ET Company Participants Mark Levin - IR Lori Woods - CEO Jonathan Hunt - CFO Conference Call Participants Mike Ott - Oppenheimer Frank Takkinen - Lake Street Presentation Operator Greetings, welcome to the Isoray'...

Revenue Increased 7% Year-Over-Year Non-Prostate Brachytherapy Revenue Increased 92% Year-Over-Year RICHLAND, Wash., Feb. 09, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE AMERICAN: ISR), a medical technology company and innovator in seed brachytherapy powering expanding tre...